NexgenRx(TSE:NXG)
CA$0.67-0.04 (-5.63%)
TSE:NXG
NexgenRx financials statements
CA$0.67
At close:-0.04 (-5.63%)
NexgenRx (NXG) Financial Statements
19 Followers
NexgenRx Financial Overview
NexgenRx's market cap is currently $50.49M. The company's EPS TTM is ―; its P/E ratio is 21.32; and it has a dividend yield of 2.82%. NexgenRx has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 10.82M | ― | $ 9.81M | $ 9.67M | $ 8.37M |
| Operating Income | $ -143.88K | ― | $ 2.20M | $ 2.16M | $ 93.52K |
| EBITDA | $ 1.15M | ― | $ 3.40M | $ 2.96M | $ 815.97K |
| Net Income | $ -331.97K | ― | $ 4.02M | $ 2.12M | $ -207.94K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 30.20M | $ 25.75M | $ 29.44M | $ 25.24M | $ 21.19M |
| Total Debt | $ 461.88K | $ 432.47K | $ 401.76K | $ 1.45M | $ 4.10M |
| Net Debt | $ -1.41M | $ -1.33M | $ -1.92M | $ 643.66K | $ 3.57M |
| Total Liabilities | $ 22.48M | $ 16.90M | $ 19.72M | $ 19.72M | $ 19.35M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ 1.03M | ― | $ 2.45M | $ 2.65M | $ 1.05M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD

